This is an old revision of the document!
BioNTech
Development of mRNA Vaccine Technology
On October 16, 2019, Nature published an article describing BioNTech's successes in testing experimental immunotherapy vaccines for cancer, and suggested the progress could be applied to solve problems like rabies and pandemic influenza.1)
1)
Dolgin, E. (2019). Unlocking the potential of vaccines built on messenger RNA. Nature, 574(7778), S10–S12. https://doi.org/10.1038/d41586-019-03072-8